Cell Lysis Market is expanding rapidly with SPX Flow introducing two new APV Rannie and Gaulin homogenizer models to improve productivity
Cell Lysis is the process of
separating individual cells from a living person's blood and then using the
individual cells to make a fresh new blood supply. Cell Lysis can also be
called cellular separation or blood banking. Cell Lysis is the process where a
person's blood is separated from their own cells. In this process, there is the
breaking down of a cell's outer membrane or cell wall and the introduction of
new blood-clotting factors, or antibodies. Over the years, the emphasis on
personalized medicine has increased across the globe. Personalized medicine
provides various advantages including improved disease detection, customized
disease prevention strategies, and reduced time, cost, and failure rate of
clinical trials. Recently, in June 2020, Infosys launched an all-new
Personalized Medicine solution for the pharmaceutical industry, which leverages
SAP Analytics Cloud solution. Hence, such factors can augment growth of the
cell lysis market.
Another key factor governing the
development of the market is increasing government expenditure on research and
development. Governments in many countries are investing significantly in
research and development activities in the field of biotechnology and
biopharmaceutical. Thus, these factors can stimulate growth of the cell
lysis market. Recently, in April 2020, SPX Flow launched two new APV
Rannie and Gaulin homogenizer models to improve productivity.
When it comes to regional impact,
North America seems to be gaining significant traction in the cell lysis market.
This is typically due to the fact that governments in the U.S. and Canada are
supporting molecular biology research, cancer research, and precision medicine.
Besides, high private investment in R&D activities is likely to accelerate
the regional market. On the contrary, Asia Pacific is registering a positive
outlook due to growing interest of key companies.
Cell Lysis also has its use in the
treatment of cancer. When Cancerous cells are undergoing chemotherapy the best
solution to kill these would be the use of the Cell Lysis process. Cancerous
cells are known to secrete a lot of growth hormone into the blood, which in
turn stimulates the proliferation of other cancerous cells. The Cell Lysis
process does not only kill the Cancerous cells but also the normal skin cells
and also the blood cells carry the Cancerous material with them. As a result of
this, the patient is treated with great pain-free medication. However, certain
factors pertaining to the said market can limit future development. For instance,
high costs associated with cell-based research and instruments as well as
stringent regulatory compliance can impede growth of the cell lysis market.

Comments
Post a Comment